MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 ShotsZacks Investment Research • 05/21/25
Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside PotentialZacks Investment Research • 05/20/25
4 Blue-Chip Stocks With Huge Dividends at 52-Week Lows Are Table-Pounding Buys24/7 Wall Street • 05/20/25
Astellas Presents New Data that Explores Potential of its Cancer Therapies at 2025 ASCO Annual MeetingPRNewsWire • 05/19/25
High-Yield Dividend Portfolios Outperform: These Are Our 5 Favorite Stock Picks24/7 Wall Street • 05/19/25
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend IncomeThe Motley Fool • 05/16/25